Tenet Healthcare (THC) PT Raised to $100 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Nasdaq lags peers as Netflix, chip stocks drag; AmEx lifts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Wall St indexes split, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Jabil falls after placing CEO on paid leave amid internal investigation
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
THC BioMed Announces Shipment to Yukon
July 23, 2021 8:00 AM EDTTHC.CSETHCBFÂ -Â OTCTFHD.F
VANCOUVER, BC, July 23, 2021 /PRNewswire/ -Â THC BioMed Intl Ltd. ("THC BioMed" or the "Company" is pleased to announced that it has completed its first shipment to Yukon Cannabis. The shipment contains dried cannabis and cannabis cookies.
... More
Tenet Reports Second Quarter 2021 Results; Raises 2021 Financial Guidance
July 21, 2021 4:10 PM EDTNet income from continuing operations available to common shareholders in Q221 of $120 million versus net income from continuing operations of $88 million in Q220 Consolidated Adjusted EBITDA in Q221 of $834 million ($810 million excluding $24 million of COVID stimulus grant income) versus $732 million in Q220 ($209 million excluding $523 million of grant income) Diluted earnings per share from continuing operations available to common shareholders in Q221 of $1.11 compared to $0.83 in Q220; Adjusted diluted earnings per share from continuing operations of $1.59 in Q221 compared to $1.26 in Q220 Same-hospital adjusted... More
